214 related articles for article (PubMed ID: 21194538)
1. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy.
Tikoo K; Sane MS; Gupta C
Toxicol Appl Pharmacol; 2011 Mar; 251(3):191-200. PubMed ID: 21194538
[TBL] [Abstract][Full Text] [Related]
2. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts.
Choi HJ; Seon MR; Lim SS; Kim JS; Chun HS; Park JH
Exp Biol Med (Maywood); 2008 Dec; 233(12):1554-60. PubMed ID: 18849542
[TBL] [Abstract][Full Text] [Related]
3. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
Li W; Xu B; Xu J; Wu XL
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
[TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
5. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
6. Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity.
Xin YF; Zhou GL; Shen M; Chen YX; Liu SP; Chen GC; Chen H; You ZQ; Xuan YX
Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):421-6. PubMed ID: 17971065
[TBL] [Abstract][Full Text] [Related]
7. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells.
Du G; Lin H; Wang M; Zhang S; Wu X; Lu L; Ji L; Yu L
Cancer Chemother Pharmacol; 2010 Jan; 65(2):277-87. PubMed ID: 19466611
[TBL] [Abstract][Full Text] [Related]
8. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
9. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
[TBL] [Abstract][Full Text] [Related]
10. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells.
Di X; Gennings C; Bear HD; Graham LJ; Sheth CM; White KL; Gewirtz DA
Breast Cancer Res Treat; 2010 Nov; 124(2):349-60. PubMed ID: 20155316
[TBL] [Abstract][Full Text] [Related]
11. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
12. TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.
Kleiner Y; Bar-Am O; Amit T; Berdichevski A; Liani E; Maor G; Reiter I; Youdim MB; Binah O
J Cardiovasc Pharmacol; 2008 Sep; 52(3):268-77. PubMed ID: 18806608
[TBL] [Abstract][Full Text] [Related]
13. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.
Hoke EM; Maylock CA; Shacter E
Free Radic Biol Med; 2005 Aug; 39(3):403-11. PubMed ID: 15993339
[TBL] [Abstract][Full Text] [Related]
14. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
[TBL] [Abstract][Full Text] [Related]
15. Regulation of breast cancer response to chemotherapy by fibulin-1.
Pupa SM; Giuffré S; Castiglioni F; Bertola L; Cantú M; Bongarzone I; Baldassari P; Mortarini R; Argraves WS; Anichini A; Menard S; Tagliabue E
Cancer Res; 2007 May; 67(9):4271-7. PubMed ID: 17483339
[TBL] [Abstract][Full Text] [Related]
16. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.
Kim DS; Woo ER; Chae SW; Ha KC; Lee GH; Hong ST; Kwon DY; Kim MS; Jung YK; Kim HM; Kim HK; Kim HR; Chae HJ
Life Sci; 2007 Jan; 80(4):314-23. PubMed ID: 17034819
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C
Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of stress responses of H9c2 rat cardiomyoblasts following treatment with doxorubicin and tBOOH.
Döhrmann M; Schorr A; Hülsenbeck J; Rasmussen TL; Issinger OG; Fritz G
Exp Cell Res; 2012 Apr; 318(6):779-88. PubMed ID: 22265794
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
